Author: Plosker Greg L. Lyseng-Williamson Katherine A.
Publisher: Adis International
ISSN: 1173-8804
Source: BioDrugs, Vol.21, Iss.2, 2007-01, pp. : 125-132
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab in Crohn's Disease: A Viewpoint by Maikel P. Peppelenbosch
BioDrugs, Vol. 21, Iss. 2, 2007-01 ,pp. :
Adalimumab in Crohn's Disease: A Viewpoint by Brian Bressler
BioDrugs, Vol. 21, Iss. 2, 2007-01 ,pp. :
Certolizumab Pegol: In Crohn's Disease
By Blick Stephanie K.A. Curran Monique P.
BioDrugs, Vol. 21, Iss. 3, 2007-01 ,pp. :
Spotlight on Infliximab in Crohn Disease and Rheumatoid Arthritis
By Siddiqui M. Asif A. Scott Lesley J.
BioDrugs, Vol. 20, Iss. 1, 2006-01 ,pp. :
Certolizumab Pegol in Crohn's Disease: A Viewpoint by Trevor A. Winter
BioDrugs, Vol. 21, Iss. 3, 2007-01 ,pp. :